Table 1.

Characteristics of studies included in Bioproject.

Country, Year, Project description	BioProject accession	Study setting	Study population	Sample type
China, 2020 Alterations of the fecal microbiota in Chinese patients with multiple sclerosis	PRJNA628832	Zhejiang University	34 MS	Fecal samples
China, 2019 In this study, four patients of cirrhosis accompanied with hepatic encephalopathy (CHE) were enrolled, with their healthy relatives as the controls, and paired comparison analysis was carried out. Fresh fecal samples were collected from participants, and subjected to Illumina MiSeq high throughput sequencing of 16S rRNA regions.	PRJNA534155	Institute of Disease Control and Prevention	4 hepatic encephalopathy; healthy controls (n = 4)	Fecal samples
USA, 2020 C. bolteae is elevated in NMOSD in India and shares sequence similarity with AQP4	PRJNA662563	Brigham and Women's Hospital	39 NMOSD patients; 36 matched controls	Fecal samples
China, 2020 gut microbiota in children with autism spectrum disorder accompanied with sleep disorder	PRJNA615774	Chongqing Medical University affiliated Children Hospital	ND	Fecal samples
South America Ecuador, 2019 Analysis of the intestinal and oropharyngeal microbiome, nutritional and immunological profile of children with Autism Spectrum Disorder (ASD) compared with children without	PRJEB27306	Universidad San Francisco de Quito	ND	Fecal samples
Korea, 2020 Gut microbiota of Human with mild anxiety/depression	PRJNA678145	Kyung Hee University	ND	Fecal samples
Japan 2020 Specific bacterial species relating to the development and progression of multiple sclerosis	PRJDB7752	Laboratory for Microbiome Sciences, Center for Integrative Medical Sciences, RIKEN	ND	Fecal samples

ND, not described; NMOSD, neuromyelitis optica spectrum disorders; MS, multiple sclerosis.